Search Results

You are looking at 1 - 9 of 9 items for :

  • P. aeruginosa x
Clear All
Open access

Eslam El-Sawy, Fatma Bassyouni, Sherifa Abu-Bakr, Hanaa Rady and Mohamed Abdlla

, Susceptibility Testing: Diffusion Test Procedures , in Manual of Clinical Microbiology (Eds. E.H. Lennette, A. Balows, W.J. Hausler Jr. and J.P. Truant), 3 rd ed., American Society for Microbiology, Washington (DS) 1980, pp. 463-474. T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Meth.   65 (1983) 55-63; DOI: 10.1038/nbt089.716. J.M. William, A.V. Edward, D.I. Dale and S. Youqing, Progesterone facilitates cisplatin toxicity in

Open access

Mohammed Afzal Azam, Loganathan Dharanya, Charu Chandrakant Mehta and Sumit Sachdeva

References 1. G. Dannhardt and W. Kiefer, Cyclooxygenase inhibitors-current status and future prospects, Eur. J. Med. Chem. 36 (2001) 109-126; DOI: 10.1016/S0223-5234(01)01197-7. 2. Y. Song, D. T. Connor, A. D. Sercel, R. J. Sorenson, R. Doubleday, P. C. Unangst, B. D. Roth, V. G. Beylin, R. B. Gilbertsen, K. Chan, D. J. Schrier, A. Guglietta, D. A. Bornemeier and R. D. Dyer, Synthesis, structure-activity relationships, and in vivo evaluations of substituted di- tert -butylphenols as a novel class of potent

Open access

Anna A. Tolmacheva, Eugene A. Rogozhin and Dmitry G. Deryabin

-1307; DOI: 10.1172/ JCI200320074. 4. M. C. Marjorie, Plant products as antimicrobial agents, Clin. Microbiol. Rev. 4 (1999) 564-582. 5. D. Trombetta, F. Castelli, M. G. Sarpietro, V. Venuti, M. Cristani, C. Daniele, A. Saija, G. Mazzanti and G. Bisignano, Mechanisms of antibacterial action of three monoterpenes, Antimicrob. Agents Chemother. 49 (2005) 2474-2478; DOI: 10.1128/AAC.49.6.2474-2478.2005. 6. W. C. Fuqua, S. C. Winans and E. P. Greenberg, Quorum sensing in bacteria: the LuxR-LuxI family of cell density

Open access

N. Kučerka, E. Dushanov, Kt. Kholmurodov, J. Katsaras and D. Uhríková

References [1] Allen, W. J., Lemkul, J. A., and Bevan, D. R. GridMAT-MD: a Grid-Based Membrane Analysis Tool for Use With Molecular Dynamics. J.Comput.Chem. 2009;30(12):1952-8. [2] Alsop, R. J., Maria, Schober R., and Rheinstadter, M. C. Swelling of Phospholipid Membranes by Divalent Metal Ions Depends on the Location of the Ions in the Bilayers. Soft Matter 10-8- 2016;12(32):6737-48. [3] Castillo, N., Monticelli, L., Barnoud, J., and Tieleman, D. P. Free Energy of WALP23 Dimer Association in DMPC, DPPC, and

Open access

Mosaad Mohamed, Ramdan El-Domany and Rania Abd El-Hameed

,4-diamino-5-methyl-6-substituted-pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors, J. Med. Chem. 47 (2004) 3689--3692; DOI: 10.1021/jm0306327. P. M. Traxler, P. Furet, H. Mett, E. Buchdunger, T. Meyer and N. Lydon, 4-(Phenylamino)pyrrolopyrimidines: Potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase, J. Med. Chem. 39 (1996) 2285--2290; DOI: 10.1021/jm960118j. M. S. Mohamed, A. E. Rashad, M. E. A. Zaki and S. S. Fatahala, Synthesis and antimicrobial screening

Open access

Marta Panas, Adriana Baryliyak and Olena Korniychuk

communities in sickness and in health. Trends. Microbiol., 13. 589. 2005. 11. Juliana P.M.L. et al.: The antimicrobial activity of photodynamic therapy against Streptococcus mutans using dif ferent photosensitizers. J. Photochem. and Photobiol. B: Biology, 106. 40. 2012. 12. Nagata J. Y. et al.: Antibacterial photodynamic therapy for dental caries: Evaluation of the photosensitizers used and light source properties. Photodiag. and Photodyn. Ther., 9. 122. 2012. 13. Paschoal M. A. et al.: Photodynamic potential of curcumin and

Open access

Ioana Mihaiela Ciuca, Liviu Laurentiu Pop, Alexandru Florin Rogobete, Monica Marc, Liviu Athos Tamas and Florin George Horhat

“Leeds criteria” for Pseudomonas aeruginosa infection in a cystic fibrosis centre. Eur Respir J 2006;27(5):937-43 10. Lee TWR, Brownlee KG, Convay SP, Denton M, Littlewood JM. Evaluation of a new definition of chronic P. aeruginosa infection in cystic fibrosis. J Cyst Fibros 2003;2:29- 34 11. Tiddens HAWM, Donaldson SH, Rosenfeld M, Paré PD. Cystic fibrosis lung disease starts in the small airways: Can we treat it more effectively? Pediatr Pulmonol 2010;45:107-117 12. Farrell PM, Rosenstein BJ, White TB, et al. Guidelines

Open access

Sonia Elena Popovici, Ovidiu Horea Bedreag and Dorel Sandesc

References 1. Bueno-Cvanillas A, Delgado-Rodriguez M, et al. Influence of nosocomial infection on mortality rate in an intensive care unit. Crit Care Med 1994; 22(1):55-60 2. Wilson DJ. Insights from genomics into bacterial pathogen populations. PLoS Pat-hog. 2012;8(9):e1002874. 3. Nemec A, Musilek M, Mxinerova M, etl al. Acinetobacter beijerinckii sp nov and Acinetobacter gyllenbergii sp nov., haemolytic organisms isolated from humans. Int J Syst Evol Microbiol 2009;59:118-124. 4. Bouvet, P. J., and P. A. Grimont. 1986. Taxonomy of the

Open access

Robert Ivaşcu, Ligia Torsin, Darius Morlova, Alina Stanca, Mihai Neguţu, Silvius Negoiţă and Mădălina Duţu

References 1. Allen GB, Parsons PE. Acute Respiratory Failure due to Acute Respiratory Distress Syndrome and Pulmonary Edema. In: Irwin RS, Lilly CM, Mayo PH, Rippe JM, editors. Irwin and Rippe’s Intensive Care Medicine. 8th Editio. Philadelphia: Lippincott Williams & Wilkins; 2018. p. 1454–67. 2. Ruthman CA, Festic E. Emerging Therapies for the Prevention of Acute Respiratory Distress Syndrome. Ther Adv Respir Dis. 2015;9(4):173–87. 3. Ware LB, Bastarache JA, Bernard GR. Acute Respiratory Distress Syndrome. In: Vincent J-L, Abraham E, Moore FA